Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Atlas Venture Opportunity Fund II, L.P.
10% owner at Korro Bio · 10% owner at Dyne Therapeutics. Filing since 12 Dec 2022.
CIK 0001885327
KRRO
Korro Bio, Inc.
10% owner · 1 trade
DYN
Dyne Therapeutics, Inc.
10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
KRRO
Korro Bio, Inc.
22 Apr 2024
10% owner
Bought
17,857
$999.99K
10.1%
DYN
Dyne Therapeutics, Inc.
12 Dec 2022
10% owner
Bought
934,581
$10.00M
opened
2 decisions on file.